ERBB2 and gastroesophageal reflux disease: Cohort studies have demonstrated that GERD is a significant risk factor for EGFR-mutant lung cancer (Choi et al., 2019), and acid bile salt mimics GERD exposure and enhances ERBB2-mediated activation of immune cell/inflammatory pathways (Patankar et al., 2022).